InvestorsHub Logo
Followers 48
Posts 6527
Boards Moderated 0
Alias Born 09/02/2006

Re: None

Thursday, 03/30/2023 7:09:08 AM

Thursday, March 30, 2023 7:09:08 AM

Post# of 356
Details on the Company's two presentations are provided below.

AD/PD™ 2023
Abstract Number: 3080
Title: Phase 3 Clinical Studies in Alzheimer's and Parkinson's Disease; Interim Analysis of the Parkinson's Clinical Study
Date: Thursday, March 30, 2023
Presenter: Cheng Fang, Ph.D.

https://tinyurl.com/583mexd6

Abstract Number: 3114
Title: Do Mouse Data Lie? For Buntanetap They Totally Predict Human Outcome
Date: Friday, March 31, 2023
Presenter: Maria Maccecchini, Ph.D
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANVS News